Physician profile
Heather Hensarling
NPI 1366176695
$802.83
in general payments reported to CMS, 2019-2025
14 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $27.71 · 2023: $223 · 2024: $265 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.12 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $192.66 | 2023-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $116.52 | 2025 | Veozah |
| Exeltis, USA INC. | $74.06 | 2024 | Slynd |
| Mayne Pharma Commercial LLC | $63.07 | 2023 | |
| Pfizer INC. | $56.30 | 2023-2025 | |
| Organon LLC | $52.60 | 2023-2025 | Nexplanon |
| Becton, Dickinson and Company | $48.46 | 2023 | Channel Drain |
| Biogen, INC. | $42.48 | 2025 | Zurzuvae |
| Ethicon US, LLC | $34.50 | 2024 | Dermabond Prineo |
| Shield Therapeutics INC | $30.97 | 2023-2024 | Accrufer |
| Baxter Healthcare | $27.71 | 2022 | |
| Exact Sciences Corporation | $23.35 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $20.69 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Hensarling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.